Cizzle Biotechnology Holdings PLC (CIZ) Stock Statistics & Valuation Metrics

Cizzle Biotechnology Holdings PLC has a market cap or net worth of GBX 5.28M. The enterprise value is GBX 10.43M.

Market Cap

GBX 5.28M

Enterprise Value

GBX 10.43M

Cizzle Biotechnology Holdings PLC has 480,320,340 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

480,320,340

Owned by Insiders

―

Owned by Institutions

―

Cizzle Biotechnology Holdings PLC’s return on equity (ROE) is 2.03 and return on invested capital (ROIC) is 203.78%.

Return on Equity (ROE)

2.03

Return on Assets (ROA)

-2.82

Return on Invested Capital (ROIC)

203.78%

Return on Capital Employed (ROCE)

2.21

Revenue Per Employee

0

Profits Per Employee

-138.20K

Employee Count

5

Asset Turnover

0.00

Inventory Turnover

0.00

The current PE Ratio of Cizzle Biotechnology Holdings PLC is -6.88. Cizzle Biotechnology Holdings PLC’s PEG ratio is -0.14.

PE Ratio

-6.88

PS Ratio

0.00

PB Ratio

-13.20

Price to FCF

-8.79

Price to Operating Cash Flow

-8.36

PEG Ratio

-0.14

In the last 12 months, Cizzle Biotechnology Holdings PLC had revenue of 0 and earned -691.00K in profits. Earnings per share was -0.00.

Revenue

0

Gross Profit

0

Operating Income

-753.00K

Pretax Income

-751.00K

Net Income

-691.00K

EBITDA

-753.00K

Earnings Per Share (EPS)

-0.00

In the last 12 months, operating cash flow was -532.00K and capital expenditures 0, giving a free cash flow of -532.00K billion.

Operating Cash Flow

-532.00K

Free Cash Flow

-532.00K

Free Cash Flow per Share

-0.00

Cizzle Biotechnology Holdings PLC pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-11.38%

Earnings Yield

-14.66%

Beta

-0.91

52-Week Price Change

-24.14%

50-Day Moving Average

1.42

200-Day Moving Average

1.98

Relative Strength Index (RSI)

30.92

Average Volume (3m)

2.17M

Cizzle Biotechnology Holdings PLC upcoming earnings date is May 05, 2027, TBA (Not Confirmed).

Last Earnings Date

Sep 30, 2026

Next Earnings Date

May 05, 2027

Ex-Dividend Date

―

Cizzle Biotechnology Holdings PLC as a current ratio of 0.42, with Debt / Equity ratio of 0.00%

Current Ratio

0.42

Quick Ratio

0.42

Debt to Market Cap

0.00

Net Debt to EBITDA

0.15

Interest Coverage Ratio

0.00

In the past 12 months, Cizzle Biotechnology Holdings PLC has paid -60.00K in taxes.

Income Tax

-60.00K

Effective Tax Rate

0.08

Cizzle Biotechnology Holdings PLC EV to EBITDA ratio is -6.34, with an EV/FCF ratio of -8.63.

EV to Sales

0.00

EV to EBITDA

-6.34

EV to Free Cash Flow

-8.63

EV to Operating Cash Flow

-8.63

Cizzle Biotechnology Holdings PLC has GBX 81.00K in cash and marketable securities with GBX 0.00 in debt, giving a net cash position of GBX 81.00K billion.

Cash & Marketable Securities

GBX 81.00K

Total Debt

GBX 0.00

Net Cash

GBX 81.00K

Net Cash Per Share

GBX 0.00

Tangible Book Value Per Share

GBX 0.00

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin

0.00%

Operating Margin

0.00%

Pretax Margin

0.00%

Net Profit Margin

0.00%

EBITDA Margin

0.00%

EBIT Margin

0.00%

The average price target for Cizzle Biotechnology Holdings PLC is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

―

EPS Growth Forecast

42.86%

Smart Score

―

AI Score

43